New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.

Alzheimer’s disease, a debilitating, cognitive, and neurological disorder, gradually erodes a person’s memory, language skills and thinking skills.

While coffee is known to provide multiple health benefits, the expert suggested drinking the beverage without sugar and with less milk.